187 related articles for article (PubMed ID: 28268596)
1. Evaluation of multidrug cancer chronotherapy based on cell cycle model under influences of circadian clock.
Inokawa H; Katayama N; Nakao M
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():1439-1442. PubMed ID: 28268596
[TBL] [Abstract][Full Text] [Related]
2. Circadian clock and cell cycle: Cancer and chronotherapy.
Yao J; He C; Zhao W; Hu N; Long D
Acta Histochem; 2021 Dec; 123(8):151816. PubMed ID: 34800857
[TBL] [Abstract][Full Text] [Related]
3. Modeling circadian clock-cell cycle interaction effects on cell population growth rates.
El Cheikh R; Bernard S; El Khatib N
J Theor Biol; 2014 Dec; 363():318-31. PubMed ID: 25152215
[TBL] [Abstract][Full Text] [Related]
4. Chronopharmacological strategies focused on chrono-drug discovery.
Ohdo S; Koyanagi S; Matsunaga N
Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
[TBL] [Abstract][Full Text] [Related]
5. Molecular Links between the Circadian Clock and the Cell Cycle.
Farshadi E; van der Horst GTJ; Chaves I
J Mol Biol; 2020 May; 432(12):3515-3524. PubMed ID: 32304699
[TBL] [Abstract][Full Text] [Related]
6. Chronotherapy and the molecular clock: Clinical implications in oncology.
Innominato PF; Lévi FA; Bjarnason GA
Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
[TBL] [Abstract][Full Text] [Related]
7. Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.
Ozturk N; Ozturk D; Kavakli IH; Okyar A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039812
[TBL] [Abstract][Full Text] [Related]
8. Identification of Circadian Determinants of Cancer Chronotherapy through In Vitro Chronopharmacology and Mathematical Modeling.
Dulong S; Ballesta A; Okyar A; Lévi F
Mol Cancer Ther; 2015 Sep; 14(9):2154-64. PubMed ID: 26141947
[TBL] [Abstract][Full Text] [Related]
9. Modeling the Circadian Control of the Cell Cycle and Its Consequences for Cancer Chronotherapy.
Leung C; Gérard C; Gonze D
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106812
[TBL] [Abstract][Full Text] [Related]
10. Circadian clock, cancer, and chemotherapy.
Sancar A; Lindsey-Boltz LA; Gaddameedhi S; Selby CP; Ye R; Chiou YY; Kemp MG; Hu J; Lee JH; Ozturk N
Biochemistry; 2015 Jan; 54(2):110-23. PubMed ID: 25302769
[TBL] [Abstract][Full Text] [Related]
11. Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F
Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
[TBL] [Abstract][Full Text] [Related]
12. The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
Ye Y; Xiang Y; Ozguc FM; Kim Y; Liu CJ; Park PK; Hu Q; Diao L; Lou Y; Lin C; Guo AY; Zhou B; Wang L; Chen Z; Takahashi JS; Mills GB; Yoo SH; Han L
Cell Syst; 2018 Mar; 6(3):314-328.e2. PubMed ID: 29525205
[TBL] [Abstract][Full Text] [Related]
13. The circadian timing system in clinical oncology.
Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
[TBL] [Abstract][Full Text] [Related]
14. Circadian clock and cancer therapy: an unexpected journey.
Kondratov R
Ann Med; 2014 Jun; 46(4):189-90. PubMed ID: 24915534
[TBL] [Abstract][Full Text] [Related]
15. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
[TBL] [Abstract][Full Text] [Related]
16. Exploring the link between chronobiology and drug delivery: effects on cancer therapy.
Albuquerque T; Neves AR; Quintela T; Costa D
J Mol Med (Berl); 2021 Oct; 99(10):1349-1371. PubMed ID: 34213595
[TBL] [Abstract][Full Text] [Related]
17. WNT Takes Two to Tango: Molecular Links between the Circadian Clock and the Cell Cycle in Adult Stem Cells.
Matsu-Ura T; Moore SR; Hong CI
J Biol Rhythms; 2018 Feb; 33(1):5-14. PubMed ID: 29277155
[TBL] [Abstract][Full Text] [Related]
18. Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy.
Lévi FA; Okyar A; Hadadi E; Innominato PF; Ballesta A
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():89-114. PubMed ID: 37722720
[TBL] [Abstract][Full Text] [Related]
19. Circadian chronotherapy for human cancers.
Lévi F
Lancet Oncol; 2001 May; 2(5):307-15. PubMed ID: 11905786
[TBL] [Abstract][Full Text] [Related]
20. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects.
Ortiz-Tudela E; Mteyrek A; Ballesta A; Innominato PF; Lévi F
Handb Exp Pharmacol; 2013; (217):261-88. PubMed ID: 23604483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
